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Bladder cancer is one of the most common cancers among men in industrialized
countries and on the global level incidence and mortality rates are increasing. In spite
of progress in surgical treatment and chemotherapy, the prognosis remains poor for
patients with muscle-invasive bladder cancer. Therefore, there is a great need for the
development of novel therapeutic approaches. The human amniotic membrane (hAM)
is a multi-layered membrane that comprises the innermost part of the placenta. It has
unique properties that make it suitable for clinical use, such as the ability to promote
wound healing and decrease scarring, low immunogenicity, and immunomodulatory,
antimicrobial and anticancer properties. This study aimed to investigate the effect of
(i) hAM-derived cells and (ii) hAM scaffolds on the growth dynamics, proliferation rate,
and invasive potential of muscle-invasive bladder cancer T24 cells. Our results show
that 24 and 48 h of co-culturing T24 cells with hAM-derived cells (at 1:1 and 1:4
ratios) diminished the proliferation rate of T24 cells. Furthermore, when seeded on hAM
scaffolds, namely (1) epithelium of hAM (e-hAM), (2) basal lamina of hAM (denuded;
d-hAM), and (3) stroma of hAM (s-hAM), the growth dynamic of T24 cells was altered
and proliferation was reduced, even more so by the e-hAM scaffolds. Importantly,
despite their muscle-invasive potential, the T24 cells did not disrupt the basal lamina
of hAM scaffolds. Furthermore, we observed a decrease in the expression of epithelial-
mesenchymal transition (EMT) markers N-cadherin, Snail and Slug in T24 cells grown
on hAM scaffolds and individual T24 cells even expressed epithelial markers E-cadherin
and occludin. Our study brings new knowledge on basic mechanisms of hAM affecting
bladder carcinogenesis and the results serve as a good foundation for further research
into the potential of hAM-derived cells and the hAM extracellular matrix to serve as a
novel bladder cancer treatment.
Keywords: amniotic membrane, bladder cancer, tissue engineering, regenerative medicine, anticancer, amniotic
epithelial cells, amniotic mesenchymal stromal cells, urothelial cancer cells
Abbreviations: d-hAM, hAM scaffold, in which the epithelium was removed (deepithelized hAM); the T24 cells were seeded
on the basal lamina; e-hAM, hAM scaffold; the T24 cells were seeded on the hAM epithelium; hAEC, human amniotic
epithelial cells; hAM, human amniotic membrane; hAMSC, human amniotic mesenchymal stromal cells; s-hAM, hAM
scaffold; the T24 cells were seeded on the hAM stroma.
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INTRODUCTION
Approximately 549,400 people were diagnosed with
bladder cancer worldwide in 2018 and as its incidence
continues to increase, bladder cancer is classified among
the five most common malignancies in industrialized
countries (Zieger, 2008; Ferlay et al., 2015; Bray
et al., 2018). Overall, men are more affected than
women (3.2:0.9 ratio), and bladder cancer incidence
and mortality are higher in high-income countries in
comparison to low-income countries (Sanli et al., 2017;
Cumberbatch et al., 2018).
There are two main clinical phenotypes of bladder cancer,
namely non-muscle-invasive bladder cancer and muscle-invasive
bladder cancer. At initial diagnosis, 75% of cases are non-
muscle invasive bladder cancer and 25% are muscle-invasive
bladder cancer. Moreover, 50–70% of patients with non-muscle-
invasive bladder cancer have recurrences after surgical removal
of the primary tumor, and 10–20% of those also progress
to muscle-invasive bladder cancer (Soloway, 2013; Yun and
Kim, 2013; Ye et al., 2014; Scarpato et al., 2015; Mari et al.,
2017). The development of multifocal tumors dispersed in
the urothelium is common. The multifocal tumors may be
recognized already at first diagnosis of cancer, but more
often arise after resection of the primary tumor (Habuchi,
2005; Kim et al., 2012). The development of muscle-invasive
tumors (T2–T4 stage) presents a critical clinical step in
carcinogenesis, which results in a significantly lower 5-year
survival rate, and therefore demands more aggressive therapy
(Mari et al., 2017; Sanli et al., 2017). Hence, it is imperative
to develop new therapeutic approaches that will target bladder
cancer cells with high proliferative and invasive potential,
which will increase the success of muscle-invasive bladder
cancer treatment.
The human amniotic membrane (hAM) is the innermost
layer of the fetal membranes, which protects the embryo
and later the fetus. hAM is composed of a monolayer of
human amniotic epithelial cells (hAEC), the basal lamina
and thick avascular stroma, which is further divided into
the compact layer, a layer of human amniotic mesenchymal
stromal cells (hAMSC) and a spongy layer (Rocha and Baptista,
2015). Moreover, the hAM and cells derived thereof have
many properties which make it suitable for clinical use,
such as low immunogenicity (Kubo et al., 2001; Szekeres-
Bartho, 2002), immunomodulatory activity (Kronsteiner et al.,
2011; Li et al., 2015; Magatti et al., 2015, 2017; Pianta
et al., 2015) and antifibrotic activity (Tseng et al., 1999; Kim
et al., 2000; Sant’anna et al., 2011), angiogenic and anti-
angiogenic activity (Hao et al., 2000; Paeini-Vayghan et al., 2011;
Niknejad et al., 2013a), promotion of epithelisation (Fukuda
et al., 1999; Kim et al., 2000; Jin et al., 2015), antimicrobial
activity (Talmi et al., 1991; Kjaergaard et al., 2001; Mencucci
et al., 2006; Tehrani et al., 2013; Mao et al., 2017, 2018;
Šket et al., 2019; Ramuta et al., 2020b) and also anticancer
activity (Jiao et al., 2012; Magatti et al., 2012; Niknejad et al.,
2013b, 2014, 2016; Mamede et al., 2014, 2015; Riedel et al.,
2019).
The use of hAM in the clinic is increasing. While the hAM
is already widely applied in ophthalmology, the potential of
its use in various medical fields is demonstrated also by the
increasing number of clinical trials reporting the utilization of
hAM1. The use of hAM is relevant also in the field of urology,
which has been demonstrated by several in vitro and in vivo
studies. Previously we have shown that hAM as a scaffold enables
the development of tissue-engineered urothelium, which is in
molecular and ultrastructural properties comparable to native
urothelium (Jerman et al., 2014). Other studies have already used
the hAM for bladder (Shakeri et al., 2008; Adamowicz et al.,
2016; Barski et al., 2017) and urethral reconstruction (Shakeri
et al., 2009; Wang et al., 2014) in animal models. Moreover,
hAM was also used for reconstructive surgery of the ureteral
obstruction in patients with extensive ureteral strictures (Koziak
et al., 2007) and reconstructive surgery of strictured urethra
(Koziak et al., 2004).
The anticancer properties of hAM started gaining recognition
in recent years. Magatti et al. (2012) and Bu et al. (2017)
have demonstrated that hAMSC and hAEC induce a cell
cycle arrest in the G0/G1 phase in several cancer cell lines.
Moreover, several research groups have shown that hAM and
its derivatives promote apoptosis in cancer cells and also
reduce the viability and affect the metabolism of cancer cells
(Jiao et al., 2012; Niknejad et al., 2013b, 2014; Mamede
et al., 2014, 2015, 2016; Riedel et al., 2019). However, to
the best of our knowledge, the effect of hAM on bladder
cancer has not yet been extensively investigated. Therefore, the
aim of our study was to investigate the effect of (i) hAM-
derived cells and (ii) hAM scaffolds on the growth dynamics,




The use of hAM was approved by the National Medical Ethics
Committee of the Republic of Slovenia (decree numbers 43/12/09
and 0120-179/2018/5) and prepared according to the standard
procedures (Mikek et al., 2004; Soncini et al., 2007; Jerman
et al., 2014; Magatti et al., 2015; Cargnoni et al., 2018). Briefly,
to prepare hAM scaffolds, 15 placentas were obtained with
written informed consent at the time of elective cesarean sections
from healthy volunteers, who were serologically negative for
HIV, syphilis and hepatitis B and C. For hAM-derived cells
(hAMSC and hAEC), human term placentas (n = 10) were
collected from healthy women serologically negative for HIV,
hepatitis B and C, after vaginal delivery or cesarean section
at term after obtaining informed written consent according
to the guidelines set by the Comitato Etico Provinciale of
Brescia number NP 2243 (19/01/2016), Italy. For the preparation
of primary urothelial cells, porcine urinary bladders were
obtained from a local abattoir. The experiments were approved
by the Veterinary Administration of the Slovenian Ministry
1ClinicalTrials.gov
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of Agriculture and Forestry in compliance with the Animal
Health Protection Act and the Instructions for Granting Permits
for Animal Experimentation for Scientific Purposes (U34453-
15/2013/2).
Cell Cultures
In the experiments, the T24 cell line that originated from human
invasive urothelial neoplasm (ATCC, United States) was used
as a model of muscle-invasive bladder cancer cells (passages 5–
30). The T24 cells were seeded at seeding density of 5 × 104
cells/cm2 and cultured at 37◦C and 5% CO2 in culture medium
A-DMEM+F12 as described previously (Resnik et al., 2015,
2019; Višnjar et al., 2017). The culture medium consisted of
1:1 mixture of A-DMEM medium (Gibco, United States) and
F12 (Sigma-Aldrich, United States), supplemented with 5% fetal
bovine serum (FBS) (Invitrogen), 4 mM Glutamax (Gibco,
United States), 100 µg/ml streptomycin, and 100 U/ml penicillin
(Thermo Fisher Scientific, United States).
The CFPAC-1 cell line that originated from human pancreatic
adenocarcinoma (ATCC, United States), Saos-2 cell line that
originated from human bone osteosarcoma (kindly provided by
the Centro Substrati Cellulari, Istituto Zooprofilattico of Brescia,
Italy), and human fibroblasts isolated from a skin biopsy. Skin-
derived fibroblasts were obtained after informed consent as
described by Magatti et al. (2012), served as a control. CFPAC-
1, Saos-2 and skin-derived human fibroblast cells were seeded at
seeding density of 1 × 104 cells/cm2 and cultured at 37◦C and
5% CO2 in RPMI completed medium composed of RPMI 1640
medium (Sigma-Aldrich, United States) supplemented with 10%
fetal bovine serum (FBS) (Sigma-Aldrich, United States), 2 mM
L-glutamine (Sigma-Aldrich, United States), 100 U/mL penicillin
(Sigma-Aldrich, United States), and 100 µg/mL streptomycin
(Sigma-Aldrich, United States).
Primary normal porcine urothelial cell cultures (NPU
cells) were established as described previously (Kreft et al.,
2005; Višnjar et al., 2012) and cultured in culture medium
consisting of equal parts of MCDB153 medium (Sigma-Aldrich,
United States) and Advanced Dulbecco’s modified essential
medium (Invitrogen, Life Technologies, United States), 0.1 mM
phosphoethanolamine (Sigma-Aldrich), 15 µg/ml adenine
(Sigma-Aldrich, United States), 0.5 µg/ml hydrocortisone
(Sigma-Aldrich, United States), 5 µg/ml insulin (Sigma-
Aldrich, United States), 4 mM glutamax (Gibco, United States),
100 µg/ml streptomycin and 100 U/ml penicillin (Thermo
Fisher Scientific, United States). The NPU cells (passages
4–10) were plated on synthetic scaffolds (porous membrane,
pore diameter 0.4 µm; BD Falcon, Corning, United States)
at a seeding density of 1 × 105 cells/cm2. When the NPU
cells reached confluence, they were cultured in the culture
medium without serum, but with a physiological calcium
concentration of 2.7 mM. The NPU cells were maintained
at 37◦C and 5% CO2 for 3 weeks. The experiments were
approved by the Veterinary Administration of the Slovenian
Ministry of Agriculture and Forestry in compliance with
the Animal Health Protection Act and the Instructions
for Granting Permits for Animal Experimentation for
Scientific Purposes.
Isolation, Culture, Expansion and
Characterization of hAEC and hAMSC
Isolation of hAEC and hAMSC from human term placentas
was performed as described previously (Soncini et al., 2007;
Magatti et al., 2015; Cargnoni et al., 2018). Briefly, the amniotic
membrane was first manually separated from chorion and
washed with 0.9% NaCl containing 100 U/ml penicillin and
100 µg/ml streptomycin (Sigma-Aldrich, United States) and
2.5 mg/ml amphotericin B (Sigma-Aldrich, United States). For
hAMSC isolation, hAM was cut into pieces (3 cm × 3 cm),
which were then sterilized by brief incubation in 0.9% NaCl
and 2.5% Eso Jod (Esoform, Italy) and then in 500 U/ml
penicillin, 500 µg/ml streptomycin, 12.5 µg/ml amphotericin B
and 1.87 mg/ml Cefamezin (Teva Italia SrL, Italy). The pieces
were then incubated for 9 min at 37◦C in HBSS (Sigma-
Aldrich, United States) containing 2.5 U/ml dispase (VWR
International Srl, Italy), and digested in complete RPMI 1640
medium (Sigma-Aldrich, United States), supplemented with
0.94 mg/ml collagenase (Roche, Germany) and 10 µg/ml DNase
(Roche, Germany) for 2.5–3.0 h at 37◦C. The amniotic epithelium
was then removed by centrifugation (3 min at 150 g) and hAMSC
were passed through 100-µm and 70-µm cell strainers and then
centrifuged. Then hAMSC (p0) were plated (seeding density
1 × 104 cells/cm2) and cultured at 37◦C and 5% CO2 in DMEM
complete medium supplemented with 10% heat-inactivated
fetal bovine serum (FBS; Sigma-Aldrich, United States), 2 mM
L-glutamine (Sigma-Aldrich, United States), 100 U/ml penicillin
and 100 µg/ml streptomycin or cryopreserved in 10% DMSO
(Sigma-Aldrich) supplemented with 90% FBS until use. When
hAMSC reached confluence, they were subcultured at a seeding
density 1× 104/cm2.
For hAEC isolation, hAM was cut into pieces (15 cm× 15 cm)
which were incubated for 10 min at 37◦C in PBS containing
0.5 mM EDTA and 100 U/ml penicillin and 100 µg/ml
streptomycin, followed by a 5-min incubation in 1×
trypsin/EDTA solution (Sigma-Aldrich, United States) at
37◦C. The debris was discarded and the pieces were incubated
for 10 min at 37◦C in 1× trypsin-EDTA solution, followed
by washing in PBS and they were digested a second time in
1× trypsin/EDTA for 10 min at 37◦C. Cells from digestions
were collected and centrifuged at 300 g for 10 min and the cell
suspensions were filtered through a 70 µm cell strainer (BD
Biosciences, United States), centrifuged again, plated (hAEC
p0; seeding density 1.2 × 105/cm2) and cultured at 37◦C
and 5% CO2 in DMEM/F12 complete medium. When hAEC
reached confluence, they were subcultured at a seeding density
4× 104/cm2.
For phenotype evaluation, hAEC and hAMSC were
trypsinized and then washed with FACS buffer (0.1% sodium
azide (Sigma-Aldrich, United States) and 0.1% FBS (Sigma-
Aldrich) in PBS), followed by a 20-min incubation at 4◦C with
anti-human fluorescein isothiocyanate- (FITC) or phyoerythrin-
(PE) or allophycocyanin (APC)-conjugated antibodies or
isotype controls (specified bellow) with 20 ml/ml polyglobin
(Gammagard, United States) prepared in PBS with 1% BSA
to block non-specific binding. After incubation, the cells were
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washed with FACS buffer and the dead cells were eliminated
by the propidium iodide (PI) staining. The following clones
of the monoclonal antibodies were used: CD73 (clone AD2),
CD90 (5E10), CD45 (HI30), CD105 (266), CD13 (L138), CD66b
(G10F5) (all from BD Biosciences, United States), and CD324
(67A4) (Miltenyi, Germany).
Analysis of the Effect of hAMSC and
hAEC on the Proliferation of T24 Cells
The effect of amniotic-derived cells on the proliferation of T24
cells was evaluated either in direct contact or with physical
separation using transwell chambers, as described previously
(Magatti et al., 2012). Briefly, for direct contact experiments,
hAMSC and hAEC cells (p2) and control cells CFPAC-1,
Saos-2, and skin-derived human fibroblast cells were plated in
flat-bottom 96-well plates (Corning, United States) in RPMI
complete medium at seeding density 1 × 104 cells/well and
4 × 104 cells/well. For non-contact experiments, hAMSC,
hAEC, CFPAC-1, Saos-2, and skin-derived human fibroblast
cells were plated in the upper compartment (0.4-µm pore,
polycarbonate membranes, 96-well plates, Corning) of transwell
chambers (1 × 104 cells/transwell and 4 × 104 cells/transwell
of RPMI complete medium). hAMSC, hAEC, CFPAC-1, Saos-
2, and fibroblast cells were gamma-irradiated to block their
proliferation ensuring the maintenance of the correct ratio
during co-culture (30 Gy for hAMSC, hAEC, and fibroblast
dermal cells; 50 Gy for CFPAC-1, and Saos-2 cells). Therefore,
any proliferation observed would be attributed only to the
T24 cell line, which was added after 24 h to each well in
direct contact with hAMSC, hAEC, CFPAC-1, Saos-2, and skin-
derived human fibroblast cells or in the lower compartment
of transwell chambers (seeding density 1 × 104 cells/well in
A-DMEM+F12 complete medium). After additional 24 and
48 h in culture, the proliferation of cancer cells was assessed
by adding [3H]-thymidine (1 µCi/well; Perkin Elmer, Life
Sciences, Belgium) for 16–18 h and then by harvesting the
cells with a Filtermate Harvester (Perkin Elmer, Belgium).
Thymidine incorporation was measured by using a microplate
scintillation and luminescence counter (Top Count NXT; Perkin
Elmer, Belgium).
Preparation of hAM Scaffolds
Human amniotic membrane was manually separated from the
chorion and washed with sterile phosphate-buffered saline (PBS),
which contained antibiotics (50 µg/mL penicillin, 50 µg/mL
streptomycin, 100 µg/mL neomycin) and an antimycotic
(2,5 µg/mL amphotericin B). Then hAM was cut into pieces
(4 cm × 4 cm) and cryopreserved at –80◦C in MEM (Modified
Eagle’s Medium; Gibco, United States) and glycerol (volume
ratio 1:1) until use. After thawing at room temperature, hAMs
were washed with sterile PBS (two times for 5 min) and
A-DMEM+F12 culture medium (two times for 5 min). Next,
the hAMs were fastened in membrane holders of 14 or 25 mm
in diameter (CellCrown; Scaffdex, Finland) with the amniotic
epithelium facing up (epithelial hAM: e-hAM; denuded hAM:
d-hAM) or with the hAM stromal side facing up (stromal
hAM: s-hAM). To obtain d-hAM, hAEC were removed by a
15 min incubation in the proteolytic enzyme thermolysin (1:50
in PBS; Thermolysin from Bacillus thermoproteolyticus rokko,
Sigma-Aldrich, United States) at 37◦C. After incubation, d-hAM
scaffolds were rinsed with PBS and incubated for 15 min at room
temperature on a shaker to remove cellular debris.
Before seeding, T24 cells were labeled with a fluorescent
dye DiI (Invitrogen). Briefly, T24 cells were incubated in a
mixture of the DiI dye (Thermo Fisher Scientific, United States)
and A-DMEM+F12 culture medium (1:1000) and incubated
at 37◦C for 30 min. Next, T24 cells were rinsed with culture
medium (three times for 5 min). Labeled T24 cells were seeded
on hAM scaffolds and synthetic scaffolds (porous membrane,
pore diameter 0.4 µm; BD Falcon, Corning, United States)
at a seeding density of 5 × 104 cells/cm2 and were then
maintained at 37◦C and 5% CO2 for 3 weeks. The culture
medium was changed 3 times a week and each time before
and after taking the images. After 3 weeks in culture,
samples were further processed for light microscopy (paraffin
sections and cryosections) and transmission and scanning
electron microscopy.
Analysis of Proliferation of T24 Cells
Grown on hAM Scaffolds and Synthetic
Scaffolds
To evaluate the growth of T24 cells on hAM scaffolds and
synthetic scaffolds, T24 cells were observed with an inverted
fluorescence microscope Eclipse TE300 (Nikon, Japan). Namely,
on days 1, 2, 3, 7, 14, and 21 we took seven images of each scaffold
at random positions. The area of the hAM scaffolds covered with
T24 cells was evaluated with ImageJ software (Schneider et al.,
2012), measuring this area as a percentage of total field view area.
The proliferation rate of T24 cells grown on hAM and
synthetic scaffolds was analyzed by labeling the proliferating cells
with the Click-it Plus EdU Alexa Fluor 488 Imaging Kit (Thermo
Fisher Scientific, United States) and subsequent analysis with
ImageJ software. Briefly, 24 h before the analysis the T24 cells
grown on hAM and synthetic scaffolds were incubated in the
culture medium A-DMEM+F12 supplemented with 10 µM 5-
ethynyl-2′-deoxyuridine (EdU). To evaluate the proliferation of
hAM-derived cells, the e-hAM scaffolds alone were incubated in
the culture medium A-DMEM+F12 supplemented with 10 µM
EdU. After 24 h, hAM scaffolds and synthetic scaffolds were
fixed for 15 min with 4% formaldehyde at room temperature,
washed three times with 3% BSA/PBS, permeabilized with
0.5% Triton-X-100 in PBS and incubated at room temperature
for 20 min. After permeabilization, samples were washed
three times with 3% BSA/PBS. To stain the proliferating
T24 cells, Click-it Plus reaction buffer containing AlexaFluor
picolyl azide was prepared according to the manufacturer’s
instructions and samples were incubated with the reaction
buffer at room temperature for 30 min. Afterward, samples
were washed three times with 3% BSA/PBS, nuclei were stained
with DAPI and samples were examined with a fluorescence
microscope AxioImager.Z1 equipped with ApoTome (Zeiss,
Germany). Furthermore, 10 images for each sample were taken
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To prepare paraffin sections, hAM scaffolds with T24 cells were
fixed with 4% formaldehyde (w/v) overnight and then paraffin
sections were prepared as previously described (Jerman et al.,
2014). Briefly, samples were dehydrated through a graded series
of ethanol into xylene, followed by embedment in paraffin wax
and preparation of paraffin sections. Then these were stained with
Periodic Acid Schiff stain (PAS) for neutral proteoglycans.
For immunofluorescence, hAM scaffolds and synthetic
scaffolds with T24 cells were fixed in (a) 4% formaldehyde
(w/v) for 15 min, washed in PBS for 30 min, embedded
in OCT and then cryosections were prepared, and (b) in
ice-cold absolute ethanol for 20 min at room temperature.
After blocking in 3% BSA/PBS for 45 min, samples were
incubated in polyclonal anti-collagen IV antibody (dilution
1:200; ab6586, Abcam, United Kingdom), rabbit polyclonal
anti-N-cadherin antibody (dilution 1:100; ab18203; Abcam,
United Kingdom), rabbit polyclonal anti-occludin antibody
(dilution 1:30; 71–1500, Invitrogen, Thermo Fisher Scientific,
United States), mouse polyclonal anti-E-cadherin antibody
(dilution 1:20; 610182 BD-Pharmingem, United States)
and rabbit polyclonal anti-Snail + Slug antibody (dilution
1:1000; ab180714, Abcam, United Kingdom) overnight at
4◦C. As a positive control for occludin and E-cadherin
stainings, the NPU cells were analyzed. The next day
samples were washed in PBS and then incubated in goat
anti-rabbit and goat anti-mouse IgG conjugated with Alexa
Fluor 488 or Alexa Fluor 555 for 2 h at room temperature
(dilution 1:400; Molecular Probes, Invitrogen, Thermo Fisher
Scientific, United States). Afterward, DAPI was applied
to stain nuclei. Samples were examined with the inverted
fluorescence microscope Eclipse TE300 (Nikon, Japan) and
a fluorescence microscope AxioImager.Z1 equipped with
ApoTome (Zeiss, Germany).
Western Blot Analysis
For Western blot analysis, T24 cells grown on hAM and synthetic
scaffolds were lysed in ice-cold extraction buffer, comprised of a
deionized H20, 0.5 M TRIS HCl, 10% Sodium Dodecyl Sulfate
(SDS) supplemented with a cocktail of protease and phosphatase
inhibitors (Thermo Fisher Scientific, United States). Total protein
quantity was determined using the Pierce BCA Protein Assay
Kit (Thermo Fisher Scientific, United States). Protein extracts
(50 µg) were separated using 4–20% Novex WedgeWell Tris-
Glycine Gels (Invitrogen, Carlsbad, CA, United States) and then
transferred onto the nitrocellulose membranes (Sigma-Adrich,
St. Louis, MO, United States). The membranes were blocked with
5% skim milk in 0.1% Tris-buffered saline/Tween 20 (TBS-T) for
1 h at room temperature. Next, the membranes were incubated
overnight with primary antibodies: anti-N-cadherin (dilution
1:1000; ab18203, Abcam, United Kingdom), anti-Snail + Slug
(dilution 1:1000; ab180714, Abcam, United Kingdom), anti-actin
(dilution 1:2000; A2066, Sigma-Adrich, United States), anti-
collagen IV (dilution 1:1000; ab6586, Abcam, United Kingdom)
at 4◦C with gentle shaking. Next day, the membranes were
washed with TBS-T and incubated with HRP-conjugated goat
anti-rabbit IgG antibody (dilution 1:1000; A6154, Sigma-Adrich,
United States) for 1 h at room temperature with gentle
shaking. Finally, SuperSignal West Pico Chemiluminescent
Substrate (Thermo Scientific, Waltham, MA, United States)
was used to visualize the bands. Densitometric analysis was
performed using the Image J software. Actin served as a
loading control.
Transmission and Scanning Electron
Microscopy
Human amniotic membrane scaffolds and synthetic scaffolds
with T24 cells were prepared for transmission and scanning
electron microscopy as described previously (Višnjar et al.,
2012; Jerman et al., 2014). Briefly, samples for scanning
electron microscopy were fixed with 2% formaldehyde and
2% glutaraldehyde in 0.2 M cacodylate buffer, pH 7.4 for
3 h at 4◦C. Fixation was followed by overnight rinsing in
a 0.2 M cacodylate buffer and then by postfixation in 1%
(w/v) osmium tetroxide in the same buffer for 2 h at room
temperature. Samples were then dehydrated in a graded
series of alcohol, followed by acetone and immersed in
hexamethyldisilazane and dried at room temperature. Afterward,
the samples were sputtered with gold and examined by
a scanning electron microscope (Tescan Vega3). Samples
for transmission electron microscopy (TEM) were fixed
with 3% formaldehyde and 3% glutaraldehyde in 0.1 M
cacodylate buffer for 3 h at 4◦C. Fixation was followed
by overnight rinsing 0.1 M cacodylate buffer and then by
postfixation with 2% (w/v) osmium tetroxide for 1 h at room
temperature. Samples were then dehydrated in a graded series
of ethanol and embedded in Epon (Serva Electrophoresis).
Ultrathin sections were contrasted with uranyl acetate and lead
citrate and examined by a transmission electron microscope
(Philips CM100).
Statistical Analyses
All data were calculated from 3 to 5 biological samples of
hAM and at least 3–10 technical repeats for each biological
sample. Data are presented as mean ± SE. Statistical analysis
was performed using a two-tailed Student’s t-test or two-
way analysis of variance (ANOVA) when appropriate,
adjusted by Tukey’s or Sidak’s method. Statistical analysis
was performed using Prism 8 (GraphPad Software, La Jolla,
CA, United States). p-values of <0.05 were considered
statistically significant.
Data Availability
The authors declare that all data supporting the findings
of this study are available within the manuscript.
All information about the materials and methods
used are available also in the Protocols.io database
(Ramuta et al., 2020a).
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FIGURE 1 | hAMSC and hAEC decrease the proliferation of T24 cells when grown in direct co-culture for 24 and 48 h. T24 cells were cultured alone or in the
presence of different gamma-irradiated cell types (hAMSC or hAEC, CFPAC-1, Saos-2, dermal fibroblast cells). Cultures were performed in both contact (A,B) and
transwell settings (C,D) at T24:gamma-irradiated cell ratios of 1:1 and 1:4. After 24 h (A,C) or 48 h (B,D) T24 cell proliferation was assessed by [3H]-thymidine
incorporation. Data are expressed as violin plot of more than four independent experiments for each condition, five to nine biological samples of hAEC and hAMSC
were used. *p < 0.05, **p < 0.01; ***p < 0.001.
RESULTS
Effect of hAM-Derived Cells on the
Proliferation of Muscle-Invasive Bladder
Cancer Cells
To test the effect of hAM-derived cells on the proliferation of
T24 cells, we grew them in direct co-culture with hAEC and
hAMSC cells, namely in 1:4 and 1:1 T24:hAM cell ratios. Then
we analyzed the proliferation of T24 cells 24 h (Figure 1A)
and 48 h (Figure 1B) after co-culture. Our results show that
hAEC and hAMSC decrease T24 cell proliferation when cultured
in direct contact with T24 cells and stronger effects were
observed after 48 h of culture and at a T24:hAMSC/hAEC
ratio of 1:4. Indeed, after 24 h in co-culture, hAMSC decreased
the proliferation of T24 cells on average by 31% (1:4 ratio;
p < 0.05) and 11% (ratio 1:1), respectively. Moreover, when
grown in co-culture with hAEC, the percentage of proliferating
T24 cells significantly decreased by approximately 52% (1:4
ratio; p < 0.001) and 30% (1:1 ratio; p < 0.05), respectively
(Figure 1A). After 48 h in co-culture, hAMSC inhibited the
proliferation of T24 cancer cells by 53% (1:4 ratio; p < 0.001)
and 21% (1:1 ratio; p < 0.05), while hAEC inhibited T24 cell
proliferation by 57% (1:4 ratio; p < 0.001) and 31% (1:1 ratio;
p < 0.001) (Figure 1B).
To investigate if any anti-proliferative effects were observed
also in absence of cell-contact, co-cultures were physically
separated by a transwell system. In this non-contact setting, we
did observe a slight decrease of T24 proliferation after both 24 h
(Figure 1C) and 48 h (Figure 1D) of culture, suggesting the
need of cell-contact in the hAM-derived cell reduction of T24
cell proliferation.
In addition, to test whether these results are specific to
human hAM-derived cells, and whether the co-culture condition
alone or rather the decreased surface area available for cell
growth, is responsible for the decrease in proliferation of
T24 cells, we cultured T24 with the cystic fibrosis pancreatic
adenocarcinoma (CFPAC-1) and Saos-2 cells which have an
epithelial-like morphology similar to hAEC, or with skin-derived
fibroblasts which are stromal cells similar to hAMSC. Co-culture
with CFPAC-1 cells for 24 h (Figure 1A) and 48 h (Figure 1B), at
both T24:CFPAC-1 of 1:4 and 1:1, had no statistically significant
effect on T24 cell proliferation Similarly, at both ratios tested,
Soas cells had no statistically significant effect on T24 cell
proliferation when cultured in contact with T24 cells for 24 h
(Figure 1A). After 48 h of co-culture, we observed a reduction
of T24 cancer cell proliferation only when co-culture with Saos-2
cells was performed at 1:4 ratio (inhibition of 53%; p< 0.001), but
not when cultured at 1:1 ratio (reduction of 11%; not significant)
(Figure 1B). Instead, the stromal fibroblast cells were able to
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FIGURE 2 | hAM scaffolds change the growth dynamic of T24 cells. T24 cells were seeded on (A) the hAM epithelium (e-hAM), (B) denuded hAM (d-hAM) without
hAM epithelium but preserved basal lamina, (C) hAM stroma (s-hAM) of inverted hAM, and (D) on the synthetic scaffold. When grown on the hAM scaffolds, T24
cells growth was restricted. The growth restriction effect was pronounced especially by the e-hAM scaffold, followed by s-hAM and d-hAM scaffolds, especially in
the first 3 days of culture (E) (p < 0.001). After 3 weeks in culture, T24 cells grown on the e-hAM (F) and s-hAM (H) scaffolds formed a 1–2 layered epithelium and
on the d-hAM scaffolds they formed a 1–3 layered epithelium (G). On the synthetic scaffolds T24 cells grew in 2–6 layers (I). Scale bars: 50 µm.
inhibit the proliferation of T24 cells after 24 h (Figure 1A) and
48 h (Figure 1B), at both ratios tested.
When cultured in the transwell system, CFPAC-1, Saos-2,
or skin-derived human fibroblast cells were unable to decrease
T24 cell proliferation at both ratios tested and both after 24 h
(Figure 1C) and 48 h (Figure 1D).
Effect of the Cells and Extracellular
Matrix in hAM Scaffolds on the Growth
Dynamics and Proliferation of
Muscle-Invasive Bladder Cancer Cells
T24 cells were seeded on the hAM and synthetic scaffolds
(Figures 2A–D), and cultured 3 weeks. First, we monitored the
growth of T24 cells by measuring the area of the scaffold covered
by T24 cells. Our results show that the growth of T24 cells was
diminished by all hAM scaffolds. The strongest growth inhibition
was observed by the e-hAM scaffold, followed by the s-hAM
scaffold. The first 3 days of culture were the most significant
in terms of hAM scaffold potential to inhibit the growth of
T24 cells. Namely, after 1 day in culture, T24 cells covered
38.09 ± 5.7% of the synthetic scaffolds, but only 8.49 ± 2.0% of
the e-hAM scaffolds, 22.51 ± 5.3% of the d-hAM scaffolds and
9.33 ± 0.8% of the s-hAM scaffolds. After 3 days in culture, T24
cells overgrew (100%) the synthetic scaffolds, but they covered
only 11.57 ± 2.7% of the e-hAM scaffolds, 47.13 ± 5.9% of the
d-hAM scaffolds and 22.20 ± 2.3% of the s-hAM scaffolds. Even
after 3 weeks in culture the T24 cells maintained confluent growth
(100%) on the synthetic scaffolds but reached only 38.01 ± 8.7%
coverage of the e-hAM scaffolds, 92.61 ± 1.85% of the d-hAM
scaffolds and 95.81 ± 0.82 of the s-hAM scaffolds (Figure 2E).
The dynamic of growth of T24 cells on the synthetic scaffolds
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TABLE 1 | hAM scaffolds diminish the proliferation rate of T24 cells.
hAM scaffolds The percentage of T24 cell proliferation on different
with T24 cells hAM scaffolds ± SE
Day 1 Day 2 Day 3
e-hAM+T24 44.9 ± 7.9 58.1 ± 2.7 59.1 ± 6.0
d-hAM+T24 46.5 ± 6.9 75.7 ± 4.5 85.2 ± 1.0
s-hAM+T24 53.8 ± 3.1 72.1 ± 3.6 48.5 ± 2.1
Synthetic
scaffold+T24
73.5 ± 1.4 95.8 ± 1.1 89.3 ± 2.3
Mean values (%) ± SE are shown. The percentage of proliferation shows the ratio
of the population of T24 cells grown on hAM scaffolds or on the synthetic scaffolds
that proliferated on days 1, 2, or 3.
was significantly different when compared to the hAM scaffolds
(p < 0.001). Moreover, on the e-hAM and s-hAM scaffolds the
T24 cells grew in a monolayer or, in rare exceptions, in two layers
(Figures 2F,H). On the d-hAM scaffolds the T24 cells grew in 1–3
layers (Figure 2G), and when cultured on the synthetic scaffolds
they grew in 2–6 layers (Figure 2I).
Furthermore, we analyzed the proliferation rate of T24 cells
grown on hAM scaffolds and the synthetic scaffolds. All hAM
scaffolds significantly changed proliferation rates of T24 cells on
days 1 and 2, while on day 3 only e-hAM and s-hAM scaffolds
significantly changed proliferation rates (p < 0.05; Table 1 and
Figure 3A). In comparison to the proliferation rate on the
synthetic scaffolds, the proliferation rate of T24 cells grown on
e-hAM scaffolds was diminished for 29% on day 1, 38% on day
2, and 30% on day 3. When grown on the d-hAM scaffolds,
the proliferation rate was diminished for 27% on day 1, for
20% on day 2, and 4% on day 3. Similarly, when grown on
the s-hAM scaffolds the proliferation rate decreased for 18%
on day 1, for 24% on day 2, and 41% on day 3 (Table 1 and
Figure 3). Furthermore, analysis of e-hAM scaffolds without
T24 cells showed that hAEC and hAMSC did not proliferate
(Figures 3B,C), which confirmed that using this assay we
quantified the proliferation of only T24 cells.
Effect of hAM Scaffolds on the Invasive
Potential of Bladder Cancer Cells and
Their Ultrastructure
Since T24 cells originate from the muscle-invasive bladder cancer,
our next goal was to evaluate whether T24 cells can have any effect
on hAM basal lamina. Therefore, we immunolabelled collagen IV
and performed a Periodic Acid-Schiff reaction (PAS). Our results
show that hAM basal lamina remained intact even after 3 weeks
in culture with T24 cells in all hAM scaffolds. The T24 cells did
not invade the extracellular matrix of any of the hAM scaffolds
(Figures 4A–F’).
To further evaluate the invasive potential of T24 cells grown
on hAM scaffolds, we examined the expression of N-cadherin, a
hallmark of epithelial-to-mesenchymal transition (EMT), which
results in the acquisition of an aggressive tumor phenotype
with enhanced migratory and invasive capacity (Mrozik et al.,
2018). We have demonstrated overall diminished expression
of N-cadherin in T24 cells grown on hAM scaffolds. Namely,
while on synthetic scaffold all T24 cells expressed N-cadherin,
on hAM scaffold only a part of T24 cells expressed N-cadherin
(Figures 5A–D’). Furthermore, the expression of N-cadherin
varied between different hAM scaffolds. When T24 cells were
grown on e-hAM scaffolds, N-cadherin expression was dispersed
in the cytoplasm (Figures 5A,A’), rarely N-cadherin was
expressed in the lateral plasma membrane on borders between
the adjoining cells (Figures 5A,A’). A similar expression of
N-cadherin was observed in T24 cells on d-hAM scaffolds
(Figures 5B,B’). In T24 cells grown on the s-hAM scaffolds
expression of N-cadherin was strongly diminished and only a
few cells expressed N-cadherin in the lateral plasma membrane
or/and in the cytoplasm (Figures 5C,C’). On the contrary,
the expression of N-cadherin in T24 cells grown on the
synthetic scaffolds was strong and localized predominantly in
the lateral plasma membrane of adjacent cells (Figures 5D,D’).
Furthermore, we also performed a western blot analysis, which
showed a significant decrease in expression levels of N-cadherin
in T24 cells grown on the hAM scaffolds in comparison to the
T24 cells grown on synthetic scaffolds (Figures 5I,J).
Next, we examined the expression of transcription factors
Snail and Slug, which are markers of EMT (Wu et al., 2013)
and are also connected with muscle invasion and metastasis in
bladder cancer. Our results show overall diminished expression
of Snail and Slug in T24 cells grown on the hAM scaffolds
(Figures 5E–G’) in comparison to the T24 cells grown on
synthetic scaffolds (Figures 5H,H’). Namely, Snail and Slug were
in T24 cells grown on hAM scaffolds detected mostly in the
cytoplasm, while they were in T24 cells grown on synthetic
scaffolds detected in mostly in the perinuclear area and also in
the cytoplasm and nuclei. Furthermore, we also performed a
western blot analysis, which confirmed the trend of diminished
expression of Snail in Slug in T24 cells grown of hAM scaffolds
observed by the immunofluorescence staining (Figures 5I,K).
With the aim of selecting appropriate loading control for data
normalization, we investigated the expression of actin in all of our
samples. Western blot analysis showed no signal for actin in the
e-hAM, d-hAM and s-hAM scaffolds without the T24 cells. This
result suggests that hAEC and/or hAMSC in the cryopreserved
hAM, which was used to prepare hAM scaffolds, are damaged
and characterized with low viability after 3 week period of
cultivation. To confirm the presence of proteins in hAM scaffolds
we additionally performed a western blot analysis of collagen IV,
which showed that most of the proteins in the hAM scaffolds
alone without the T24 cells are attributed to the extracellular
matrix compared to the hAM scaffolds with T24 cells, in which
most of the proteins are attributed to the cancer cells.
Next, we examined the expression of epithelial markers,
such as E-cadherin and occludin and performed ultrastructural
analysis of T24 cells. We found that individual T24 cells expressed
E-cadherin when grown on e-hAM and s-hAM scaffolds
(Figures 6A,A’,E,E’). E-cadherin was mainly dispersed in
cytoplasm, in few cases T24 cells grown on s-hAM scaffolds have
localized E-cadherin on the cell periphery (Figures 6A,A’,E,E’).
Contrary, none of the T24 cells grown on the synthetic scaffold
expressed E-cadherin (Figures 6C,C’G). Moreover, in normal
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FIGURE 3 | hAM scaffolds diminish the proliferation rate of T24 cells. (A) When grown on hAM scaffolds, the proliferation rate of T24 cells grown on the hAM
scaffolds was diminished in comparison to the proliferation rate of T24 cells grown on the synthetic scaffolds. The proliferation rate was most diminished on day 1 in
T24 cells grown on e-hAM and d-hAM scaffolds, and on day 3 in T24 cells grown on the s-hAM scaffolds. Data were obtained from at least 3 biological repeats and
20–30 technical repeats. (B,C) hAEC and hAMSC in e-hAM scaffolds did not proliferate, therefore, the rate proliferation of T24 cells grown on hAM scaffolds can be
attributed to the T24 cells alone. (D) The proliferating T24 cells grown on the synthetic scaffold are labeled green. Green – EdU, incorporated in the DNA of T24 cells;
blue – DAPI. Scale bars: 50 µm.
porcine urothelial cells (Figure 6H) E-cadherin was expressed on
borders between adjoining cells.
Similarly, individual T24 cells grown on hAM scaffolds
also expressed occludin (Figures 6B,B’,D,D’,F,F’). On the
hAM scaffolds the occludin was expressed mainly in the
cytoplasm of individual T24 cells, and this expression was
higher in T24 cells grown on the e-hAM and s-hAM scaffolds
(Figures 6B,B’,F,F’) than in the T24 cells grown on the d-hAM
scaffolds (Figures 6D,D’). Furthermore, the individual T24 cells
grown on the e-hAM and s-hAM scaffolds expressed occludin on
borders between adjoining cells (Figures 6B,B’,F,F’). None of the
T24 cells grown on the synthetic scaffold (Figure 6I) expressed
occludin. Importantly, such localization of occludin shows some
similarities with the expression of occludin in normal porcine
urothelial cells (Figure 6J).
The ultrastructural analysis of T24 cells on hAM and
synthetic scaffolds showed that in general, T24 cells were
more tightly attached to each other when grown on the
hAM scaffolds compared to synthetic scaffolds, where large
intercellular spaces were observed (Figure 7). Moreover, T24
cells occasionally formed tight junctions when grown on
s-hAM (Figures 7G,G’), thus corroborating occludin expression
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FIGURE 4 | Muscle-invasive T24 cells do not disrupt the basal lamina of hAM. T24 cells failed to disrupt the basal lamina (white and black arrows) of the hAM
scaffolds and to invade into the hAM extracellular matrix (A–F’). Images show T24 cells on hAM scaffolds after 3 weeks in culture. Frames mark enlarged areas
shown in (D’–F’). Green – collagen IV, DAPI – nuclei; arrows – basal lamina. Scale bars: (A–C) 50 µm, (D–F) 25 µm, and (D’–F’) 10 µm.
on borders between adjoining T24 cells demonstrated by
immunolabeling (Figures 6E,E’). On all scaffolds, the T24
had large nuclei with a relatively small amount of cytoplasm.
In few T24 cells on synthetic scaffolds, the amount of
granular endoplasmic reticulum (GER) was prominent, however,
altogether the significant ultrastructural differences in GER,
Golgi apparatus, and mitochondria between T24 cells on different
scaffolds were not noticed. The surface of T24 cells grown on
s-hAM scaffolds exhibit relatively smooth surface, while on the
synthetic scaffold the surface of T24 cells was shaped in irregular
protrusions and microvilli (Figures 7E–H’).
DISCUSSION
Despite high initial response rates to multiagent chemotherapy,
the median survival for patients with muscle-invasive
bladder cancer is 15 months and the 5-year survival rate
is only 15% (Von Der Maase et al., 2000, 2005), because
many patients experience disease relapse despite effective
therapy. Since a poor prognosis has often been attributed
to resistance to chemotherapy and radiation therapy
(Alfred Witjes et al., 2017; Mari et al., 2017), there is a great
need for the development of new therapeutic approaches for the
treatment of bladder cancer.
hAM-Derived Cells Reduce the
Proliferation of Muscle-Invasive Bladder
Cancer Cells
Herein, we show that both hAMSC and hAEC reduce the
proliferation of T24 cells, when cultured in direct contact with
T24 cells and especially when cultured at a 1:4 T24:hAM cell ratio.
Our results show some heterogeneity between different
biological samples, which can be attributed to placenta donor
heterogeneity and also to heterogeneity among cells derived
from different parts of the hAM. As Centurione et al. (2018)
have already shown, hAEC isolated from different areas of
hAM are a heterogeneous cell population and since hAEC
and hAMSC used in our experiments were isolated from
the whole hAM, some heterogeneity between different cell
populations can be attributed to this as well (Centurione
et al., 2018). In addition, different regions of the placenta
have been shown to possess different metabolic activities, which
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FIGURE 5 | hAM scaffolds affect the expression of N-cadherin and Snail+Slug in T24 cells. (A–C,A’–C’) Individual T24 cells grown on hAM scaffolds expressed
N-cadherin in the lateral plasma membrane of adjacent cells, however, in most cells N-cadherin was dispersed in the cytoplasm. (D,D’) N-cadherin was in T24 cells
grown on synthetic scaffolds mainly distributed in a continuous line at the cell periphery. Images show T24 cells on hAM scaffolds and synthetic scaffolds after
3 weeks in culture. (E–G’) Diminished expression of Snail+Slug in T24 cells grown on hAM scaffolds. Namely, Snail+Slug were expressed mostly in the cytoplasm.
(H,H’) In T24 cells grown on synthetic scaffolds Snail+Slug were mostly expressed in the perinuclear are and also in the cytoplasm and in the nucleus. Shown is the
lowest expression of N-cadherin (A–C’) observed in T24 cells on hAM-scaffolds and the representative expression of N-cadherin in T24 cells grown on synthetic
scaffolds (D,D’). Shown is the representative expression of Snail+Slug in T24 cells grown on hAM and synthetic scaffolds (E–H’). (I–K) Western blot analysis of
N-cadherin, Snail+Slug, actin and collagen IV expression in the T24 cells grown on hAM scaffolds and synthetic scaffolds and in the hAM scaffolds alone. Frames
mark enlarged areas shown in (A’–H’). Green – N-cadherin, red – Snail+Slug, DAPI – nuclei. Scale bars: (A–D) 50 µm, (E–H) 20 µm, and (A’–H’) 10 µm. *p < 0.05.
could in turn also contribute to the heterogeneity observed
(Banerjee et al., 2015, 2018; Centurione et al., 2018).
In addition to hAM-derived cells, T24 cells were co-cultured
also with the CFPAC-1, Saos-2 and skin-derived human fibroblast
cells. CFPAC-1 cells did not decrease the rate of proliferation of
T24 cells in all the co-culture conditions tested, thus suggesting
that the decrease in T24 cell proliferation observed with hAM-
derived cells could be attributed to an active mechanism and
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FIGURE 6 | Individual T24 cells grown on hAM scaffolds expressed E-cadherin and occludin. (A,A’,B,B’) Individual T24 cells grown on e-hAM scaffolds expressed
E-cadherin and occludin mainly in the cytoplasm. (C,C’,D,D’) The T24 cells grown on d-AM scaffolds did not express E-cadherin, while individual T24 cells grown on
the d-AM scaffolds did express occludin. (E,E’,F,F’) The expression of E-cadherin and occludin was most prominent in the individual T24 cells grown on s-hAM
scaffolds, in which both proteins were mainly dispersed in the cytoplasm and in some cases occludin was expressed on borders between adjoining cells. (G,I) T24
cells grown on synthetic scaffolds do not express E-cadherin nor occludin. (H,J) The strong expression of E-cadherin and occludin in normal porcine urothelial cells.
Images show T24 cells on hAM scaffolds and synthetic scaffolds after 3 weeks in culture and normal porcine urothelial (NPU) cells on synthetic scaffolds after
4 weeks in culture. Green – Occludin, E-cadherin; DAPI – nuclei. Scale bars: 20 µm.
not to medium exhaustion of nutrients or to the growth area
limitations. Moreover, since we observed no effect on T24 cell
proliferation when cultured with irradiated CFPAC-1, we could
exclude the possibility that the effect may be due to radiation-
induced bystander effects. Also the results obtained with co-
culture of T24 with Saos-2 cells (especially when culture for
24 h or at low ratio), confirm that the decrease in proliferation
of T24 cells in presence of hAM-derived cells is not due to a
simple decreased surface area available for cell growth or to the
irradiation process. When T24 cells were cultured in contact
with Saos-2 cells for 48 h and at a ratio of 1:4, or when T24
cells were cultured with skin-derived human fibroblasts, we
observed a reduction of their proliferation, indicating that the
anti-proliferative effects of hAM-derived cells are in common
with other cell types of mesodermal origin. The inhibitory effects
of human fibroblasts are not surprising considering that they
share immunosuppressive properties similar to mesenchymal
stromal cells (Haniffa et al., 2007). Moreover, our findings are
in accordance with those of other research showing that that
normal fibroblasts inhibit cancer cell proliferation and metastasis
of human prostate cancer cells (Iacopino et al., 2012; Koh
et al., 2019). Namely, Alkasalias et al. (2014) demonstrated that
inhibition is due to two different sets of molecules: (a) the
ECM and other surface proteins of fibroblasts which caused
contact-dependent inhibition of tumor cell proliferation and
(b) the soluble factors secreted by fibroblasts. However, they
showed that conditioned media obtained from fibroblasts alone
did not inhibit tumor cell proliferation and motility (Alkasalias
et al., 2014). Whether or not hAMSC, skin-derived human
fibroblasts and, partially, Saos-2 cells adopt the same mechanism
of inhibition of T24 cell proliferation needs to be addressed.
Concerning the possible mechanism used by hAM-derived cells,
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FIGURE 7 | Ultrastructure of T24 cells on hAM and synthetic scaffolds. Scanning (A–D’) and transmission (E–H’) electron microscopy images are represented. T24
cells are tightly attached (arrowheads) to each other on hAM scaffolds in contrast to synthetic scaffolds where large intercellular spaces were observed (white and
black asterisks, D’,H). Tight junction is formed between T24 cells on s-hAM (arrow, G’). Images show T24 cells on hAM scaffolds and synthetic scaffolds after
3 weeks in culture. Large inset framed with white lines show 200% enlarged image of corresponding small white framed inset (G’). Red frames mark enlarged areas
shown in (A’–D’) and (E’–H’), respectively. Scale bars: (A–D,A’–D’) 5 µm; (E–H) 2 µm; (F’,H’) 600 nm, (E’) 400 nm, and (G’) 100 nm.
Magatti et al. (2012) showed that hAMSC induce cell cycle arrest
in hematopoietic and non-hematopoietic cancer cells (Magatti
et al., 2012) and Bu et al. (2017) demonstrated that hAEC
induce cell cycle arrest in epithelial ovarian cancer cells (Bu
et al., 2017). In detail, Magatti et al. demonstrated that the cell
cycle arrest is induced by down-regulation in the expression of
positive regulators of the cell cycle (cyclins D2, E1, H; cyclin-
dependent kinases-2, -4, -6; mini-chromosome maintenance
complex, proliferating cell nuclear antigen) and upregulation of
the cell cycle inhibitors (G2 cyclin, CDK inhibitor 1A, CDK
inhibitor N2B). Furthermore, hAMSC also lead to upregulation
of the retinoblastoma protein (pRB) and downregulation of
Cullin-1 and RB-1-like protein (p107). Altogether, hAMSC
resulted in cycle arrest of cancer cells in the G0/G1 phase and
prevention of cell cycle progression to S phase (Magatti et al.,
2012). Similarly, Bu et al. showed that there was an increase
in expression of negative regulators of cell cycle progression,
namely p16INK4A and p21 and also demonstrated that TGF-β1
secreted from hAEC plays an important role in cell cycle arrest
(Bu et al., 2017). Additionally, Niknejad et al. have also shown
that cell cycle inhibition can be also caused by inhibition of
the heat shock protein 90 (HSP90) (Niknejad et al., 2013b). To
conclude, these studies indicate that a decrease in proliferation
of T24 cells, grown in co-culture with hAM-derived cells,
could be connected with the cell cycle arrest, but this requires
further investigation.
Further, to address if the anti-proliferative effect on T24
was mediated by secreted factors, we prevented the cell contact
between T24 and hAM-derived cells through the use of transwell
system. In this experimental setting, we did not observe a
significant decrease of T24 proliferation, suggesting the need
of cell-contact in the hAM-derived cells reduction of T24 cell
proliferation. These results are in accordance with previously
reported data, showing only a mild attenuation of cell growth of
breast cancer cells induced by human umbilical cord MSC when
cultured in transwell system, compared to the predominantly
effect observed in direct cell-contact (Chao et al., 2012), or with
studies using the conditioned medium from human WJ-MSC and
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reported to be unaffected on the proliferation of A549 lung cancer
cells (Hendijani et al., 2015) and SPC-A-1 lung adenocarcinoma
cells (Meng et al., 2019).
hAM Scaffolds Alter the Growth
Dynamics and Reduce Proliferation of
Muscle-Invasive Bladder Cancer Cells
To test whether hAM as a whole, i.e., hAM extracellular matrix
with hAM cells, also has anticancer effects, we seeded cancer
urothelial T24 cells on the hAM scaffolds. Our results show
that T24 cells possess an altered growth dynamic when seeded
on hAM scaffolds. Furthermore, in concordance with results of
growth dynamics, we have shown that hAM scaffolds diminish
the proliferative potential of T24 cells.
The growth-inhibitory effect of hAM scaffolds was most
prominent in the first 3 days after seeding and it subsequently
decreased. However, it is important to point out that the
beneficial effects of hAM scaffolds persisted for at least
3 weeks after seeding (e.g., effects of hAM on morphology and
ultrastructure of T24 cells). We assume that most of the various
molecules responsible for the anticancer effect were rinsed and
thus removed from the hAM scaffolds in the first days of
culture, first due to rinsing with PBS during the preparation of
scaffolds, and then during replenishing of culture medium during
culture on the scaffolds. Moreover, this could also explain why
d-hAM scaffolds had the lowest effect on the T24 cells since
the preparation of d-hAM scaffolds includes additional rinsing
steps due to the treatment with thermolysin and additionally,
also depletion of hAEC in d-hAM scaffolds could contribute to
lessened growth-inhibitory effect of d-hAM scaffolds.
hAM Scaffolds Hinder the Invasive
Potential of Bladder Cancer Cells
The T24 cell line (ATCC, HTB-4) is derived from a patient with a
transitional cell carcinoma of the urinary bladder. This muscle-
invasive cell line has been extensively used in bladder cancer
research and several studies evaluated its invasiveness (Gildea
et al., 2000; Fujiyama et al., 2001; Karam et al., 2011; Hong et al.,
2013; Ramakrishnan et al., 2018; Pang et al., 2019). For example,
Hong et al. (2013) and Pang et al. (2019) demonstrated that
the T24 cells are able to penetrate the extracellular matrix in a
Transwell cell invasion assay using Matrigel. Furthermore, Pang
et al. (2019) showed that mice, injected with T24 cells form lung
metastases and Karam et al. (2011) used the T24 cells to develop
a bladder cancer model in mice, which developed primary
tumors and subsequent metastases. Moreover, our preliminary
data show that the T24 cells are capable of extracellular matrix
degradation in scaffolds with or without the appropriate tissue
architecture. Namely, the T24 cells invade Matrigel and also
the porcine urinary bladder muscle explant culture (data not
shown). However, here we presented data, which unequivocally
show that when the T24 cells are grown on the hAM scaffolds,
even after 3 weeks in the culture, they are not able to cross
basal lamina and invade into hAM stroma, despite their potent
muscle-invasive capability.
In solid cancers local invasion and metastasis account for more
than 90% of mortality (Fernandes et al., 2015). Furthermore,
the treatment of solid cancers should be complemented with
drugs that inhibit the ability of cancer cells to invade through
extracellular matrix (Gandalovičová et al., 2017). Recently, a
group of scientists proposed the term “migrastatics” to describe
the drugs that interfere with all modes of cancer cell invasiveness
and their ability to metastasize (Gandalovičová et al., 2017; Rosel
et al., 2019). Moreover, they emphasized the importance of
targeting cells migration and/or invasion, since drug resistance,
which is the main cause of treatment failure, most often
develops due to mutations of the target (Gandalovičová et al.,
2017). Therefore, the ability of hAM to prevent disintegration
of basal lamina and invasion into hAM stroma is of the
utmost importance.
Furthermore, as the expression of N-cadherin is a hallmark
of muscle-invasive cancer cells, we evaluated its expression in
T24 cells grown on hAM scaffolds and the synthetic scaffolds
after 3 weeks in culture. Our results show that hAM scaffolds
diminish the expression of N-cadherin in T24 cells, as only a few
of the T24 cells grown on hAM scaffolds expressed N-cadherin,
while all T24 cells grown on the synthetic scaffolds expressed
N-cadherin. Furthermore, even though N-cadherin is junctional
protein and is typically expressed in lateral plasma membrane
of adjacent cells, in most T24 cells grown on hAM scaffolds,
its expression was mostly present in the cytoplasm, and not at
the cell periphery.
It is known that N-cadherin is required for pro-migratory
signaling and cell-cell adhesion between invasive cells (Sanders
et al., 1999; Shih and Yamada, 2012). Shih and Yamada (2012)
have shown that the N-cadherin depleted cells migrated more
slowly and traveled a shorter distance than wild-type single and
clustered cells in a 3D matrix. Moreover, cells with a partial
knockdown of endogenous N-cadherin (90% reduction) were
still able to migrate at a similar speed to wild-type cells but
did not migrate as far. These results indicate that N-cadherin
expression is required for the development of migratory cell
phenotype, in addition to the formation of cell-cell contacts,
and that the level of N-cadherin is critical for promoting
the formation of mechanically resilient cell-cell contacts and
the migration potential (Shih and Yamada, 2012). Therefore,
targeting N-cadherin is a promising therapeutic approach as its
downregulation leads to significant inhibition of proliferation,
migration and invasion (Bremmer et al., 2015; Gao et al.,
2019), which correlates with our own results as well even after
3 weeks in culture.
Snail and Slug are zinc-finger transcription factors that
serve as suppressors of E-cadherin transcription and promote
EMT (Yu et al., 2010; Wu et al., 2013; Ganesan et al.,
2016). Furthermore, their overexpression is linked with tumor
progression, invasiveness and poor survival (Bolós et al., 2003;
Yu et al., 2010; Nomura et al., 2013; Salehi et al., 2017). The
inhibition of Snail, Slug or Twist through siRNA or antisense
transfer leads to inhibition of tumor metastasis or growth
inhibition and increased susceptibility to chemotherapeutic
agents (Vannini et al., 2007; Zhang et al., 2008, 2010), which
demonstrates the potential of manipulating EMT markers to
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achieve a better outcome in bladder cancer treatment. Our
results show diminished expression of Snail and Slug in the
T24 cells grown on the hAM scaffolds in comparison to the
T24 cells grown on synthetic scaffolds and taken together with
the results of diminished expression of N-cadherin, collagen IV
immunostaining and histological staining, we suggest that hAM
harbors anti-cancer molecules that hinder the invasive potential
of cancer cells.
Importantly, we have also shown that individual T24 cells
grown on hAM scaffolds expressed adherence junctional
protein E-cadherin and occludin, one of the key components
of tight junctions, which are otherwise not expressed by
the T24 cells. Furthermore, T24 cells grown on hAM
scaffolds were more tightly attached to each other when
grown on the hAM scaffolds and also individual T24 cells
on the hAM scaffolds developed some signs of the apico-
basal polarity. Therefore, these changes in ultrastructure
could be associated with cell cycle arrest and also
decreased migration and invasion potential of muscle-invasive
bladder cancer cells.
The Potential of hAM Scaffolds for Use in
Regenerative and Reconstructive
Urology
Radical cystectomy is the standard of care for muscle-invasive
bladder cancer. Besides being associated with considerable
morbidity and mortality, this procedure also results in
a lower quality of life. New approaches allowing organ
preservation are being developed, most of them including
chemotherapy and radiation after aggressive transurethral
tumor resection (Chen et al., 2013; Mak et al., 2014;
Zhong et al., 2019).
We believe it is crucial that new approaches for treatment
of bladder cancer are directed also toward mechanisms related
to motility, migration and/or invasion and metastasis. Not only
hAM limits proliferation and invasion, our group has also shown
that hAM is a suitable scaffold for urothelium regeneration
since it promotes the proliferation and differentiation of normal
urothelial cells (Jerman et al., 2014). Moreover, the urothelium
established on s-hAM scaffolds has molecular and ultrastructural
properties comparable with the native urothelium (Jerman
et al., 2014). Furthermore, the suitability of hAM for bladder
reconstruction has been shown in vivo by several researchers,
used hAM for augmentation after partial cystectomy in rat
and dog models. Importantly, researchers report the successful
regeneration of bladder mucosa and neovascularization of
bladder tissue (Iijima et al., 2007; Shakeri et al., 2008;
Adamowicz et al., 2016).
To conclude, our results show for the first time that hAM
scaffolds have adverse effects on cancer urothelial cells and their
invasiveness. Therefore, further studies are needed to evaluate
the possibility of using hAM in the treatment of bladder cancer
as a post-operative wound dressing, which would diminish
adhesion of cancer urothelial cells to the exposed lamina propria,
their proliferation and invasion, as well as promote the rapid
regeneration of still normal and healthy urothelium.
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Linda Štrus in Nada Pavlica for their technical support. This
work contributes to the COST Action CA17116 International
Network for Translating Research on Perinatal Derivatives
into Therapeutic Approaches (SPRINT), supported by
COST (European Cooperation in Science and Technology).
The authors also would like to thank the physicians and
midwives of the Department of Obstetrics and Gynaecology
of Fondazione Poliambulanza-Istituto Ospedaliero, Brescia
(Italy), the personnel of the Department of Radiation Oncology
at Fondazione Poliambulanza-Istituto Ospedaliero for cell
irradiation, and the Department of Obstetrics and Gynaecology
of the University Clinical Centre Ljubljana (Slovenia).
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 15 November 2020 | Volume 8 | Article 554530
fbioe-08-554530 November 3, 2020 Time: 18:7 # 16
Ramuta et al. Amniotic Membrane and Bladder Cancer
REFERENCES
Adamowicz, J., Pokrywczynska, M., Tworkiewicz, J., Kowalczyk, T., Van Breda,
S. V., Tyloch, D., et al. (2016). New amniotic membrane based biocomposite
for future application in reconstructive urology. PLoS One 11:e0146012. doi:
10.1371/journal.pone.0146012
Alfred Witjes, J., Lebret, T., Compérat, E. M., Cowan, N. C., De Santis, M., Bruins,
H. M., et al. (2017). Updated 2016 eau guidelines on muscle-invasive and
metastatic bladder cancer. Eur. Urol. 71, 462–475. doi: 10.1016/j.eururo.2016.
06.020
Alkasalias, T., Flaberg, E., Kashuba, V., Alexeyenko, A., Pavlova, T., Savchenko, A.,
et al. (2014). Inhibition of tumor cell proliferation and motility by fibroblasts
is both contact and soluble factor dependent. Proc. Natl. Acad. Sci. U.S.A. 111,
17188–17193. doi: 10.1073/pnas.1419554111
Banerjee, A., Lindenmair, A., Hennerbichler, S., Steindorf, P., Steinborn, R., Kozlov,
A. V., et al. (2018). Cellular and site-specific mitochondrial characterization
of vital human amniotic membrane. Cell Trans. 27, 3–11. doi: 10.1177/
0963689717735332
Banerjee, A., Weidinger, A., Hofer, M., Steinborn, R., Lindenmair, A.,
Hennerbichler-Lugscheider, S., et al. (2015). Different metabolic activity in
placental and reflected regions of the human amniotic membrane. Placenta 36,
1329–1332. doi: 10.1016/j.placenta.2015.08.015
Barski, D., Gerullis, H., Ecke, T., Yang, J., Varga, G., Boros, M., et al. (2017). Bladder
reconstruction with human amniotic membrane in a xenograft rat model: a
preclinical study. Int. J. Med. Sci. 14:9.
Bolós, V., Peinado, H., Pérez-Moreno, M. A., Fraga, M. F., Esteller, M., and Cano,
A. (2003). The transcription factor Slug represses E-cadherin expression and
induces epithelial to mesenchymal transitions: a comparison with Snail and E47
repressors. J. Cell Sci. 116, 499–511. doi: 10.1242/jcs.00224
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., and Jemal, A.
(2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68,
394–424. doi: 10.3322/caac.21492
Bremmer, F., Schallenberg, S., Jarry, H., Küffer, S., Kaulfuss, S., Burfeind, P., et al.
(2015). Role of N-cadherin in proliferation, migration, and invasion of germ
cell tumours. Oncotarget 6, 33426–33437. doi: 10.18632/oncotarget.5288
Bu, S., Zhang, Q., Wang, Q., and Lai, D. (2017). Human amniotic epithelial cells
inhibit growth of epithelial ovarian cancer cells via TGF-β1-mediated cell cycle
arrest. Int. J. Oncol. 51, 1405–1414. doi: 10.3892/ijo.2017.4123
Cargnoni, A., Farigu, S., Cotti Piccinelli, E., Bonassi Signoroni, P., Romele, P.,
Vanosi, G., et al. (2018). Effect of human amniotic epithelial cells on pro-
fibrogenic resident hepatic cells in a rat model of liver fibrosis. J. Cell Mol. Med.
22, 1202–1213.
Centurione, L., Passaretta, F., Centurione, M. A., Munari, S., Vertua, E., Silini,
A., et al. (2018). Mapping of the human placenta: experimental evidence of
amniotic epithelial cell heterogeneity. Cell Trans. 27, 12–22. doi: 10.1177/
0963689717725078
Chao, K. C., Yang, H. T., and Chen, M. W. (2012). Human umbilical cord
mesenchymal stem cells suppress breast cancer tumourigenesis through direct
cell-cell contact and internalization. J. Cell Mol. Med. 16, 1803–1815. doi:
10.1111/j.1582-4934.2011.01459.x
Chen, R. C., Shipley, W. U., Efstathiou, J. A., and Zietman, A. L. (2013). Trimodality
bladder preservation therapy for muscle-invasive bladder cancer. J. Natl.
Compr. Canc. Netw. 11, 952–960.
Cumberbatch, M. G. K., Jubber, I., Black, P. C., Esperto, F., Figueroa, J. D., Kamat,
A. M., et al. (2018). Epidemiology of bladder cancer: a systematic review and
contemporary update of risk factors in 2018. Eur. Urol. 74, 784–795. doi:
10.1016/j.eururo.2018.09.001
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., et al.
(2015). Cancer incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386.
Fernandes, M., Rosel, D., and Brábek, J. (2015). Translation in solid cancer: are
size-based response criteria an anachronism? Clin. Transl. Oncol. 17, 1–10.
doi: 10.1007/s12094-014-1207-5
Fujiyama, C., Jones, A., Fuggle, S., Bicknell, R., Cranston, D., and Harris, A. L.
(2001). Human bladder cancer invasion model using rat bladder in vitro and
its use to test mechanisms and therapeutic inhibitors of invasion. Br. J. Cancer
84, 558–564. doi: 10.1054/bjoc.2000.1641
Fukuda, K., Chikama, T., Nakamura, M., and Nishida, T. (1999). Differential
distribution of subchains of the basement membrane components type IV
collagen and laminin among the amniotic membrane, cornea, and conjunctiva.
Cornea 18, 73–79. doi: 10.1097/00003226-199901000-00013
Gandalovičová, A., Rosel, D., Fernandes, M., Veselý, P., Heneberg, P., Čermák, V.,
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